BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 109864
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.109864
Table 1 Baseline characteristics of the patients
Group I (n = 24)
Group F (n = 25)
P value
mean (± SD), median (IQR)
mean (± SD), median (IQR)
Age, years6.5 (1.0-11.0) 6.0 (1.13-11.0)0.936
Sex, males 15 (62.5)18 (72.0)0.551
Duration of illness, days6.5 (4.0-14.5)5.0 (4.0-10.0)0.402
Weight, kg17.4 (12.1)15.9 (9.8)0.795
Height, cm101.7 (40.7)102.3 (29.7)0.826
HR, per min139 (27.6)154 (30.8)0.076
RR, per min45 (19.4)48 (20.9)0.837
SBPNR-3; 83.71 (16.9)NR-6; 78.90 (14.7)0.346
DBPNR-3; 38.30 (12.4)NR-7; 38.00 (15.4)0.941
MAPNR-3; 53.50 (11.1)NR-7; 51.60 (13.6)0.642
Systolic shock index = HR/SBPn = 20; 1.8 (0.58)n = 20; 1.8 (0.50)0.599
Diastolic shock index = HR/DBPn = 21; 3.976 (1.543)n = 18; 4.612 (2.066)0.278
IVC collapsibility index31.70 (22.30-39.75)34.00 (25.95-56.28)0.190
Fever 19/24 (79.2)20/25 (80.0)1.000
GCS14.50 (4.25-15.00)13.00 (7.00-15.00)0.916
Underlying comorbidity 12/24 (50.0)11/25 (44.0)0.778
Received prior intravenous antibiotics13/24 (54.2)10/25 (40.0)0.396
Warm shock; cold shock13/24 (54.2); 11/24 (45.8)8/25 (32.0); 17/25 (68.0)0.154
Compensated shock8/24 (33.3)8/25 (32.0)1.000
Hypotensive shock16/24 (66.7)17/25 (68.0)
Hypoglycemia3/24 (12.5)2/25 (8.0)0.667
Focus of infection0.111
Blood stream0/24 (0)2/25 (8.0)
Respiratory5/24 (20.8)9/25 (36.0)
Abdomen 3/24 (12.5)3/25 (12.0)
CNS5/24 (20.8)6/25 (24.0)
Joints/bones2/24 (8.3)0/25 (0)
Renal0/24 (0)3/25 (12.0)
Skin4/24 (16.7)1/25 (4.0)
Disseminated5/24 (20.8)1/25 (4.0)
pSOFA-L score12.0 (3.9)11.56 (3.7)0.687


Write to the Help Desk